Sight Sciences, Inc.
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
SGHT$10.75-2.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (Unaudited)
(in thousands, except share and per share data)
| March 31, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $108,768 | $120,357 |
| Accounts receivable, net of allowance for credit losses of $629 and $1,186 at March 31, 2025 and December 31, 2024, respectively | 9,424 | 10,786 |
| Inventory, net | 5,805 | 6,325 |
| Prepaid expenses and other current assets | 2,909 | 2,306 |
| Total current assets | 126,906 | 139,774 |
| Property and equipment, net | 1,485 | 1,580 |
| Operating lease right-of-use assets | 817 | 935 |
| Other noncurrent assets | 472 | 550 |
| Total assets | $129,680 | $142,839 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $2,765 | $1,691 |
| Accrued compensation | 5,125 | 9,680 |
| Accrued and other current liabilities | 4,232 | 4,097 |
| Total current liabilities | 12,122 | 15,468 |
| Long-term debt, net | 39,583 | 39,356 |
| Other noncurrent liabilities | 347 | 492 |
| Total liabilities | 52,052 | 55,316 |
| Commitments and contingencies (Note 6) | ||
| Stockholders’ equity: | ||
| Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2025 and December 31, 2024 | — | — |
| Common stock, par value $0.001 per share; 200,000,000 shares authorized; 51,376,751 and 50,937,999 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 51 | 51 |
| Additional paid-in-capital | 438,028 | 433,769 |
| Accumulated deficit | (360,451) | (346,297) |
| Total stockholders’ equity | 77,628 | 87,523 |
| Total liabilities and stockholders’ equity | $129,680 | $142,839 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.